Filing Flows › Comparisons › HRGN vs CNSY
Harvard Apparatus Regenerative Technology vs Cerenome: HRGN and CNSY compared
Harvard Apparatus Regenerative Technology is the larger company: $414K of revenue in its latest quarter (Q2 2026) against $411K for Cerenome (Q2 2026). Harvard Apparatus Regenerative Technology is growing faster (+31% against -70% a year earlier).
Where the money goes: HRGN and CNSY
Harvard Apparatus Regenerative Technology (HRGN) · Q2 2026
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart follows the revenue to costs, profit and cash.
Cerenome (CNSY) · Q2 2026
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
| Harvard Apparatus Regenerative Technology (HRGN) | Cerenome (CNSY) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $414K | $411K |
| Revenue growth, Y/Y | +31% | -70% |
| Operating margin | -408.7% | n/m |
| Net earnings | −$1.7M | −$9.0M |
| Net margin | -409.4% | — |
| Operating cash flow | −$569K | −$7.1M |
Questions
Which is bigger, Harvard Apparatus Regenerative Technology or Cerenome?
Harvard Apparatus Regenerative Technology is the larger company: $414K of revenue in its latest quarter (Q2 2026) against $411K for Cerenome (Q2 2026).
Is Harvard Apparatus Regenerative Technology or Cerenome growing faster?
Harvard Apparatus Regenerative Technology is growing faster (+31% against -70% a year earlier).
More: Harvard Apparatus Regenerative Technology earnings · how Harvard Apparatus Regenerative Technology makes money · Cerenome earnings · how Cerenome makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.